The Report “Cardiac Implant Devices Market – By Devices (Pacemakers, ICDs, CRTs, Coronary Stents, Heart Valves, TAVI Valves); By Condition (Myocardial Ischemia, Arrhythmias, Acute Myocardial Infarction) – With Forecast (2015-2020)”, published by MarketIntelReports, Cardiac Implants Devices Market size was $21.4 billion in 2014 and is growing at a CAGR of 12.5% from 2015 to 2020.
Browse 78 Market Tables & 53 Figures spread through 180 Pages and an in-depth TOC on “Cardiac Implant Devices Market” http://www.marketintelreports.com/report/hcr0032/cardiac-implant-devices-market-analysis-by-devices-pacemakers-icds-crts-coronary-stents-heart-valves-tavi-valves-by-condition-myocardial-ischemia-arrhythmias-acute-myocardial-infarction–with-forecast-20152020
Cardiac Implants Devices aim to treat heart ailments and monitor heart activity of patients. They detect any fluctuations in the cardiac system and deliver the information to healthcare providers in order to take appropriate action. A number of cardiovascular conditions which could not be treated by medication alone need an implantable cardiac device. Implantable cardiac devices store patient related information such as their name and records of irregular heart incidences since the last medical check-up.
The Key Global Players in Cardiac Implantable Devices Market Are
- Medtronic, Inc.
- Boston Scientific Corporation
- Jude Medical, Inc.
- Abbott Vascular Inc.
- Edwards Life-sciences Corporation.
All the 5 companies hold a significant market share in the industry globally with a few smaller players showing presence regionally.
According to a recent study from MarketIntelReports, the global Cardiac Implants Devices Market size was $21.4 billion in 2014 and is growing at a CAGR of 12.5% from 2015 to 2020. Advancement in technology, growing incidences of cardiovascular diseases such as coronary artery diseases (CAD), atrial fibrillation and aortic aneurysms and launch of new and innovative cardiac products such as leadless pacemakers, subcutaneous defibrillators (S-ICDs) are some of the key drivers for the growth of this market.
Get Sample Brochure of Report @ http://www.marketintelreports.com/pdfdownload.php?id=hcr0032
Americas and Europe occupied substantial market share of 60% and 22% respectively. It can be observed that Asia-Pacific is growing higher rate as compared to developed countries but generating lesser revenues due to detrimental factors like cost and reimbursement policies.
In recent years, the cardiac implantable devices design has witnessed a rapid change in technology in terms of improved size, battery life and device functionality. For instance, 3D printing technology is being utilized to perform virtual surgeries to optimize percutaneous intervention strategies. The technology has the potential to enhance success rate of interventional surgeries and helps in faster recovery of patients. With the increased complexity for treatment of cardiac diseases and greater mortality rates there is growing demand of new and sophisticated devices in the market. Therefore, companies are spending considerable part of revenue on R&D to bring advanced products into market to strengthen their market position over years and at the same time provide effective treatment to patients.
Bio absorbable stents have emerged as a new and effective treatment option in coronary intervention procedures. Abbott Vascular launched “Absorb”, world’s first drug eluting stent in Europe, parts of Asia Pacific and Latin America in 2012. Many Bioabsorbable stents are still in different developmental stages and medical professionals are not yet sure of its technical accuracy and patient benefits.
Smaller and leadless pacemakers equipped with advanced filters to reduce the effect of harmful electromagnetic radiation are developed. St. Jude Medical, Inc. and Medtronic, Inc. are key companies who have developed leadless pacemakers. These devices are in high demand and actively adopted by people due to ease of implantation. New subcutaneous ICD (S-ICD), is a novel device which has been introduced to market in 2012 by Boston Scientific Corporation. It is currently the only implantable defibrillator that provides protection from sudden cardiac arrest (SCA) while leaving the heart and vasculature untouched.
Cardiac Implant Devices Market– By Devices
- Cardiac Resynchronization Therapy Devices (CRT’S)
- Implantable Cardioverter Defibrillators (ICD’S)
- Implantable Cardiac Pacemakers (ICPs)
- Coronary Stents
- Heart Valve Replacement/Repair Devices
- TAVR (Transcatheter Aortic Valve Replacement) Valves
Cardiac Implant Devices Market– By Disease Conditions
- Myocardial Ischemia
- Acute Myocardial Infarction
Cardiac Implant Devices Market Classification- By Procedure
- Cardiac Resynchronization Therapy (CRT)
- Minimally Invasive Heart Surgery
- Open heart surgery
- Heart Valve Repair or Replacement
Cardiac Implant Devices Market -Geographic Analysis
- North America
Development of Transcatheter Aortic Valve Replacement (TAVI) valves based upon stents has appeared as a promising new option in recent years. The heart valves market is going to evolve primarily due to replacement of traditional heart valve surgery by TAVI which is less invasive than open heart surgery. According to MarketIntelReports analysis, the TAVR (Transcatheter Aortic Valve Replacement) Valves Market is expected to grow at a CAGR of 24% to reach $2 billion by 2020.
Order Cardiac Implant Devices Market Research (2015-2020) @ http://www.marketintelreports.com/purchase.php?id=hcr0032
MarketIntelReports (MIR) aim to empower our clients to successfully manage and outperform in their business decisions, we do this by providing Premium Market Intelligence, Strategic Insights and Databases from a range of Global Publishers.
A group of industry veterans who are well experienced in reputed international consulting firms after identifying the sourcing needs of MNCs for market intelligence, have together started this business savior MarketIntelReports.